IMMU-140

N/A

Report date: 2022/01/11 13:19:00

Base Information

Drug NameIMMU-140

Drug Alias NameIMMU-140

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)Biologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized

Mechanisms of ActionAnti-CD74DNA topoisomerase I inhibitors

TargetsHLA-DR antigens-associated invariant chainDNA topoisomerase I

Therapy Area/IndicationsHematologic NeoplasmsMelanoma

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesImmunomedics Inc

China Registration ClassN/A

Develop Information

Active CompaniesImmunomedics Inc

Inactive CompaniesN/A

Active IndicationsHematologic NeoplasmsMelanoma

Inactive IndicationsN/A

Other Information

ATC CodeN/A